Astra rebuffs ‘final’ Pfizer bid

US pharmaceutical group Pfizer appears to have lost the battle for Anglo-Swedish rival AstraZeneca. The firm’s final offer of £55 per share was rejected by Astra’s board as inadequate.

Unless shareholders put pressure on the board to reconsider before the deadline of 26 May, Pfizer will have to wait three months to make a higher offer with Astra’s approval, or six months if it wants to mount a hostile bid.

What the commentators said

“Pfizer was over-confident and never offered enough to win,” said Nils Pratley in The Guardian. A 45% premium to the target’s share price before the bid would usually be enough, but Astra defended itself very effectively.

A bid of £60 might well have tipped the balance, but by tabling a “take-it-or-leave-it” bid and urging Astra’s shareholders to revolt, the firm badly miscalculated.

“Pfizer has a risky way back into a deal,” said Chris Hughes on Breakingviews.com. It has the right to raise its final price if the offer is accepted, so it could signal to Astra’s board that if Astra were to accept £55, Pfizer would immediately significantly increase it.

But the Takeover Panel, which oversees deals in the UK, would not be keen on an attempt to bend the rules and might well block the bid.

So could Pfizer return in six months? Probably not, said Kamal Ahmed on BBC.co.uk. By then, “AstraZeneca shareholders believe the US government will have gone a long way to closing the tax loophole which was one of the reasons for Pfizer being so attracted to AstraZeneca.” The bid seems to be dead.

• Stay up to date with MoneyWeek: Follow us on TwitterFacebook and Google+

MoneyWeek magazine

Latest issue:

Magazine cover
Why you should worry about Greece

...and how to protect your wealth

The UK's best-selling financial magazine. Take a FREE trial today.
Claim 4 FREE Issues

From ADRs to Z scores – all the terms you wish you understood, but were too embarrassed to ask about.

Gervais Williams: if you want real dividend growth, buy small-cap stocks

Merryn Somerset Webb interviews small-cap stock expert Gervais Williams about how penny shares outperform blue chips 'again and again'.


Which investment platform is the right one for you?

When it comes to buying shares and funds, there are several investment platforms and brokers to choose from, with varying fees and charges. Find out which is best for you.


7 July 1753: The British Museum is established by Act of Parliament

On this day in 1753, Parliament passed the British Museum Act, providing for a public lottery to raise £300,000 to build a home for the nation's treasures.


Anatomy of a Grexit: how Greece would go about leaving the euro

Jonathan Loynes and Jennifer McKeown, economists at Capital Economics, look at the key issues and challenges of a Grexit, how it might be best managed, and set out a timetable for change.